167 related articles for article (PubMed ID: 9814992)
21. Somatic gene therapy for diabetes with an immunological safety system for complete removal of transplanted cells.
Kawakami Y; Yamaoka T; Hirochika R; Yamashita K; Itakura M; Nakauchi H
Diabetes; 1992 Aug; 41(8):956-61. PubMed ID: 1628770
[TBL] [Abstract][Full Text] [Related]
22. Failure to achieve normal metabolic response in non-obese diabetic mice and streptozotocin-induced diabetic mice after transplantation of primary murine hepatocytes electroporated with the human proinsulin gene (p3MTChins).
Lee RH; Roll G; Nguyen V; Willenbring H; Tang Q; Kang SM; Stock PG
Transplant Proc; 2014; 46(6):2002-6. PubMed ID: 25131094
[TBL] [Abstract][Full Text] [Related]
23. Genetically engineered proinsulin constitutively processed and secreted as mature, active insulin.
Groskreutz DJ; Sliwkowski MX; Gorman CM
J Biol Chem; 1994 Feb; 269(8):6241-5. PubMed ID: 8119968
[TBL] [Abstract][Full Text] [Related]
24. Processing of mutated proinsulin with tetrabasic cleavage sites to bioactive insulin in the non-endocrine cell line, COS-7.
Yanagita M; Nakayama K; Takeuchi T
FEBS Lett; 1992 Oct; 311(1):55-9. PubMed ID: 1397292
[TBL] [Abstract][Full Text] [Related]
25. Insulin gene transfer can be a new optional therapy for replacement of pancreas.
Kuzume M; Yamaguchi M; Matsumoto T; Matsumiya A; Shimura H; Nakano H; Kumada K; Takeda M
Transplant Proc; 1998 Nov; 30(7):3416. PubMed ID: 9838505
[No Abstract] [Full Text] [Related]
26. Reversal of diabetes in streptozotocin-treated rats by intramuscular injection of recombinant adeno-associated virus containing rat preproinsulin II gene.
Shah R; Sidner RA; Bochan MR; Jindal RM
Transplant Proc; 1999; 31(1-2):641-2. PubMed ID: 10083275
[No Abstract] [Full Text] [Related]
27. Construction and characterization of a recombinant adenovirus vector carrying the human preproinsulin gene under the control of the metallothionein gene promoter.
Yajima H; Kosukegawa A; Hoque MM; Shimojima T; Ishizu K; Takayama M; Sasaki Y; Sakai H; Otsuka M; Inokuchi S; Handa H
Biochem Biophys Res Commun; 1996 Dec; 229(3):778-87. PubMed ID: 8954972
[TBL] [Abstract][Full Text] [Related]
28. Hepatic expression of the human insulin gene reduces glucose levels in vivo in diabetic mice model.
Ajamian F; Titok T; Suhorada E; Ruban T; Reeben M
Diabetes Metab; 2003 Sep; 29(4 Pt 1):424-9. PubMed ID: 14526271
[TBL] [Abstract][Full Text] [Related]
29. Extrapancreatic insulin-producing cells in multiple organs in diabetes.
Kojima H; Fujimiya M; Matsumura K; Nakahara T; Hara M; Chan L
Proc Natl Acad Sci U S A; 2004 Feb; 101(8):2458-63. PubMed ID: 14983031
[TBL] [Abstract][Full Text] [Related]
30. Toward the biologic release of human insulin from skeletal muscle.
Bartlett RJ; Secore SL; Denis M; Fernandez L; Tzakis A; Alejandro R; Ricordi C
Transplant Proc; 1997 Jun; 29(4):2199-200. PubMed ID: 9193588
[No Abstract] [Full Text] [Related]
31. Tetracycline-regulated secretion of human (pro)insulin following plasmid-mediated transfection of human muscle.
Wilson MO; Scougall KT; Ratanamart J; McIntyre EA; Shaw JA
J Mol Endocrinol; 2005 Apr; 34(2):391-403. PubMed ID: 15821105
[TBL] [Abstract][Full Text] [Related]
32. Differentiation-induced insulin secretion from nonendocrine cells with engineered human proinsulin cDNA.
Yamasaki K; Sasaki T; Nemoto M; Eto Y; Tajima N
Biochem Biophys Res Commun; 1999 Nov; 265(2):361-5. PubMed ID: 10558872
[TBL] [Abstract][Full Text] [Related]
33. Intramuscular injection of naked plasmid DNA encoding human preproinsulin gene in streptozotocin-diabetes mice results in a significant reduction of blood glucose level.
Wang LY; Sun W; Chen MZ; Wang X
Sheng Li Xue Bao; 2003 Dec; 55(6):641-7. PubMed ID: 14695479
[TBL] [Abstract][Full Text] [Related]
34. Defective adenoassociated viral-mediated transfection of insulin gene by direct injection into liver parenchyma decreases blood glucose of diabetic mice.
Sugiyama A; Hattori S; Tanaka S; Isoda F; Kleopoulos S; Rosenfeld M; Kaplitt M; Sekihara H; Mobbs C
Horm Metab Res; 1997 Dec; 29(12):599-603. PubMed ID: 9497894
[TBL] [Abstract][Full Text] [Related]
35. NeuroD-betacellulin gene therapy induces islet neogenesis in the liver and reverses diabetes in mice.
Kojima H; Fujimiya M; Matsumura K; Younan P; Imaeda H; Maeda M; Chan L
Nat Med; 2003 May; 9(5):596-603. PubMed ID: 12704384
[TBL] [Abstract][Full Text] [Related]
36. Transplantation of insulin-producing cells differentiated from human periosteum-derived progenitor cells ameliorate hyperglycemia in diabetic mice.
Dao LT; Park EY; Lim SM; Choi YS; Jung HS; Jun HS
Transplantation; 2014 Nov; 98(10):1040-7. PubMed ID: 25208321
[TBL] [Abstract][Full Text] [Related]
37. Reversal of diabetes in the rat by injection of hematopoietic stem cells infected with recombinant adeno-associated virus containing the preproinsulin II gene.
Bochan MR; Shah R; Sidner RA; Jindal RM
Transplant Proc; 1999; 31(1-2):690-1. PubMed ID: 10083298
[No Abstract] [Full Text] [Related]
38. Gene therapy for streptozotocin-induced diabetic mice by electroporational transfer of naked human insulin precursor DNA into skeletal muscle in vivo.
Yin D; Tang JG
FEBS Lett; 2001 Apr; 495(1-2):16-20. PubMed ID: 11322940
[TBL] [Abstract][Full Text] [Related]
39. Treatment of diabetic mice with encapsulated fibroblasts producing human proinsulin.
Taniguchi H; Nakauchi H; Iwata H; Amemiya H; Fukao K
Transplant Proc; 1992 Dec; 24(6):2977-8. PubMed ID: 1466020
[No Abstract] [Full Text] [Related]
40. In vivo gene therapy of type I diabetic mellitus using a cationic emulsion containing an Epstein Barr Virus (EBV) based plasmid vector.
Yoo HS; Mazda O; Lee HY; Kim JC; Kwon SM; Lee JE; Kwon IC; Jeong H; Jeong YS; Jeong SY
J Control Release; 2006 May; 112(1):139-44. PubMed ID: 16530875
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
